FC
Finepoint Capital’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-179,872
| Closed | -$28M | – | 10 |
|
|
2025
Q1 | $28M | Sell |
179,872
-5,000
| -3% | -$779K | 2.14% | 5 |
|
|
2024
Q4 | $25.5M | Sell |
184,872
-5,200
| -3% | -$716K | 1.55% | 7 |
|
|
2024
Q3 | $28.4M | Buy |
190,072
+800
| +0.4% | +$119K | 2.06% | 5 |
|
|
2024
Q2 | $25.8M | Buy |
189,272
+13,600
| +8% | +$1.85M | 7.33% | 3 |
|
|
2024
Q1 | $26.6M | Buy |
175,672
+11,900
| +7% | +$1.8M | 6.81% | 3 |
|
|
2023
Q4 | $20.6M | Hold |
163,772
| – | – | 6.51% | 5 |
|
|
2023
Q3 | $15.3M | Buy |
163,772
+24,000
| +17% | +$2.25M | 7.64% | 6 |
|
|
2023
Q2 | $12.5M | Sell |
139,772
-16,300
| -10% | -$1.45M | 4.32% | 13 |
|
|
2023
Q1 | $16.7M | Buy |
156,072
+22,036
| +16% | +$2.36M | 6.39% | 7 |
|
|
2022
Q4 | $16.4M | Buy |
134,036
+10,636
| +9% | +$1.3M | 5.29% | 11 |
|
|
2022
Q3 | $12.7M | Sell |
123,400
-36,100
| -23% | -$3.73M | 4.19% | 16 |
|
|
2022
Q2 | $14.8M | Buy |
+159,500
| New | +$14.8M | 5.13% | 8 |
|